- Home
- BX vs BMY Comparison
BX vs BMY Comparison
Compare BX & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BX
- BMY
- Stock Information
- Founded
- BX 1985
- BMY 1887
- Country
- BX United States
- BMY United States
- Employees
- BX N/A
- BMY N/A
- Industry
- BX Investment Managers
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- BX Finance
- BMY Health Care
- Exchange
- BX Nasdaq
- BMY Nasdaq
- Market Cap
- BX 130.9B
- BMY 115.2B
- IPO Year
- BX 2007
- BMY N/A
- Fundamental
- Price
- BX $179.97
- BMY $56.30
- Analyst Decision
- BX Buy
- BMY Hold
- Analyst Count
- BX 18
- BMY 15
- Target Price
- BX $167.00
- BMY $56.29
- AVG Volume (30 Days)
- BX 3.5M
- BMY 10.8M
- Earning Date
- BX 01-30-2025
- BMY 02-06-2025
- Dividend Yield
- BX 1.91%
- BMY 4.41%
- EPS Growth
- BX 22.28
- BMY N/A
- EPS
- BX 2.90
- BMY N/A
- Revenue
- BX $11,138,276,000.00
- BMY $47,435,000,000.00
- Revenue This Year
- BX $52.08
- BMY $7.22
- Revenue Next Year
- BX $29.54
- BMY $0.24
- P/E Ratio
- BX $62.12
- BMY N/A
- Revenue Growth
- BX 35.11
- BMY 5.56
- 52 Week Low
- BX $115.82
- BMY $39.35
- 52 Week High
- BX $200.96
- BMY $61.08
- Technical
- Relative Strength Index (RSI)
- BX 55.65
- BMY 47.26
- Support Level
- BX $160.73
- BMY $55.08
- Resistance Level
- BX $177.47
- BMY $56.74
- Average True Range (ATR)
- BX 4.07
- BMY 0.99
- MACD
- BX 0.83
- BMY -0.07
- Stochastic Oscillator
- BX 99.35
- BMY 41.74
About BX Blackstone Inc.
Blackstone is the world's largest alternative-asset manager with $1.108 trillion in total asset under management, including $820.5 billion in fee-earning assets under management, at the end of September 2024. The company has four core business segments: private equity (25% of fee-earning AUM and 30% of base management fees), real estate (35% and 39%), credit and insurance (31% and 24%), and multi-asset investing (9% and 7%). While the firm primarily serves institutional investors (87% of AUM), it also caters to clients in the high-net-worth channel (13%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.